Global Alzheimer's Drugs Market Is Expected to Rise to US$6.4 Bn by 2025
Alzheimer's disease is a neurodegenerative disorder that causes slow decline in abilities such as thinking, reasoning, and routine daily activities, alongside memory loss. This may lead to planning or solving problems, poor judgment, lack of social activities, and personality and mood changes, which are considered the most common symptoms of Alzheimer's disease. Symptoms of Alzheimer's disease generally begin to appear in patients in their mid-sixties. As per World Alzheimer's report, one new case of AD is registered every 3.2 seconds....
View full press release